CM Life Sciences II (CMIIU) to Combine with SomaLogic in $1.23Bn Deal

CM Life Sciences II (NASDAQ:CMIIU) announced this morning that it will combine with proteomics firm SomaLogic at an enterprise value of $1.23 billion, or 14.6x its 2022E revenue. SomaLogic provides a technology platform for use both in proteomics research and medical diagnostics. The deal is expected to close in the third quarter, with SomaLogic trading
Read More